Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss.
about
The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodiesFrom Humoral Theory to Performant Risk Stratification in Kidney Transplantation.Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine.De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.Donor-Specific Antibodies in Kidney Transplant Recipients.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Evolving Approaches in the Identification of Allograft-reactive T and B Cells in Mice and Humans.Application, technical issues, and interpretation of C1q for graft outcome.Desensitisation strategies in high-risk children before kidney transplantation.T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.Utility of protocol kidney biopsies for de novo donor-specific antibodies.Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.
P2860
Q30397251-CF672CC9-DD28-4AC5-80CF-FDD5E797E59CQ33865743-2B1FAAAF-D213-4029-AE89-BCE478C499C2Q37590820-0B557045-6619-4D16-ACBE-41080B6FE626Q37641415-AF32491A-7663-4CB5-A929-A67179CF6A06Q38861456-C84112FC-B46F-4D4B-B321-C07BC7DFA39CQ39265221-2057B48F-F968-45C7-AF5F-525609B896ACQ39366396-D5B9C5C7-EDE9-4290-BDDE-979DA2CD0F14Q39366464-00B3F3A8-1772-4CE8-9C14-22C6497ED8D5Q39445381-6AF5A67B-AD0C-4C9A-B8C7-DB74D5EC386DQ47563660-1FE41931-E3EC-486B-B646-15CDBDE03782Q47595221-C8334AE5-20B7-4C3F-A7F3-359AB518CB8EQ50504222-107EC0FE-D64B-4F0D-BBC3-645214ECC6E4Q54969814-2D7B88A1-0212-4937-AB32-E4322FD5A3BCQ55509898-AB6FC818-8D62-4029-9145-58265E856A4A
P2860
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Value of Donor-Specific Anti-H ...... tion of Kidney Allograft Loss.
@en
type
label
Value of Donor-Specific Anti-H ...... tion of Kidney Allograft Loss.
@en
prefLabel
Value of Donor-Specific Anti-H ...... tion of Kidney Allograft Loss.
@en
P2093
P2860
P356
P1476
Value of Donor-Specific Anti-H ...... tion of Kidney Allograft Loss.
@en
P2093
Alexandre Loupy
Carmen Lefaucheur
Carol Bentlejewski
Christophe Legendre
Clément Gosset
Denis Glotz
Denis Viglietti
Dewi Vernerey
Jean-Paul Duong van Huyen
Olivier Aubert
P2860
P304
P356
10.1681/ASN.2016030368
P577
2016-08-04T00:00:00Z